Skip to Content
MoleculesMolecules
  • Article
  • Open Access

18 November 2026

28 Pages

Screening of Antidepressant Active Components from Thymus quinquecostatus and the Underlying Mechanisms Based on Neural Stem Cell and Glial Cell Plasticity

,
,
,
,
,
and
1
School of Life Sciences, Shaanxi Engineering & Technological Research Centre for Conservation & Utilization of Regional Biological Resources, Yan’an University, Yan’an 716000, China
2
Yan’an Engineering & Technological Research Centre for Resource Peptide Drugs, Yan’an 716000, China
3
Yan’an Key Laboratory for Neural Immuno-Tumor and Stem Cell, Yan’an 716000, China
*
Authors to whom correspondence should be addressed.
This article belongs to the Section Natural Products Chemistry

Abstract

This study aimed to screen the active components of Thymus quinquecostatus with antidepressant effects and to explore the underlying mechanisms based on hippocampal neuroplasticity. A chronic restraint stress (CRS) mouse model of depression was established. The intervention effects of five active components—thyme volatile oil, thymol, carvacrol, p-cymene, and β-caryophyllene (BCP)—were systematically evaluated using behavioral, endocrine, histomorphological, and molecular approaches (50 mg/kg, intraperitoneal injection, once daily for 14 days). All active components significantly reduced serum corticosterone levels (decreased by 27.1–64.7%, p < 0.001) and increased the sucrose preference rate (increased by 39.5–55%, p < 0.05). carvacrol and p-cymene significantly shortened immobility time in the tail suspension test (decreased by 17–20.9%), whereas thymol, BCP, and volatile oil effectively reduced feeding latency in the novelty-suppressed feeding test (decreased by 63.4–67.8%). p-cymene, BCP, and volatile oil significantly increased the number of BrdU+ proliferating cells and DCX+ immature neurons in the hippocampal dentate gyrus (p < 0.05–0.001). All five components increased the number of microglial terminal endpoints by 41–70%, indicating a shift toward a resting/anti-inflammatory phenotype, and some components also restored astrocyte morphology and density (p < 0.05). All five components significantly activated AKT (p-AKT/AKT increases of more than 91%), whereas only volatile oil, carvacrol, and p-cymene significantly activated CREB (p-CREB/CREB increases of 34–50%), suggesting that AKT/CREB signaling participates in the regulation of neuronal survival and plasticity. Collectively, these components ameliorated depression-like behaviors in mice potentially through a multi-target, heterogeneous network—including inhibiting HPA axis overactivation, promoting neurogenesis, inducing glial anti-inflammatory phenotype transformation, and activating AKT/CREB survival signaling—rather than a simple, linear synergistic mechanism. Notably, the pronounced effect of p-cymene on neurogenesis may partly reflect its higher absolute administered dose compared to its natural abundance in the volatile oil. Among them, p-cymene, BCP, carvacrol, and volatile oil displayed promising therapeutic potential. These preliminary findings provide an experimental basis for the development of natural multi-target antidepressants based on neural stem cell–glial cell network regulation.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.